Caricamento...
Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective
BACKGROUND: A number of diabetic patients with diabetic neuropathy, in India, were treated with epalrestat, an aldose reductase inhibitor. In this study, more than 2000 patients with diabetic neuropathy, who were treated with epalrestat for 3-12 months, were analyzed to assess the efficacy and the a...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications
2008
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2771994/ https://ncbi.nlm.nih.gov/pubmed/19893679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0972-2327.44558 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|